Patent · US Active

Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors

US11814386B2 · kind B2 · utility

1Cited by

20References

20Claims

0Family size

Assignee

FORMA Therapeutics, Inc. · US

Inventors

Alex J. Buckmelter · Acton, US
Justin Andrew Caravella · Cambridge, US
Hongbin Li · Newtown, US
Matthew W. Martin · Arlington, US
Steven Mischke · Waltham, US
David Richard · Monroe, US
Angela V. West · Watertown, US

Key dates

Filing date	Oct 20, 2022
Grant date	Nov 14, 2023
Priority date	—
Expiry date	Oct 20, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/107
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The disclosure relates to USP30 Inhibitor Compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and medical uses involving same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.